U.S. RESEARCH ROUNDUP-AT&T, ATI, California Resources

July 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AT&T, ATI and California Resources, on Monday.

HIGHLIGHTS

* AT&T Inc : JP Morgan adds stock to its u.s. analyst focus list

* ATI Inc : JP Morgan removes stock from its u.s. analyst focus list

* California Resources Corp : Gerdes Energy Research cuts to neutral from buy

* First Citizens Bancshares : JP Morgan adds stock to its u.s. analyst focus list

* Illumina Inc : RBC cuts target price to $242 from $249

Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.

* Accolade Inc : Stephens cuts target price to $10 from $14

* Apellis Pharmaceuticals Inc : Mizuho cuts target price to $49 from $52

* AT&T Inc : JP Morgan adds stock to its u.s. analyst focus list

* ATI Inc : JP Morgan removes stock from its u.s. analyst focus list

* California Resources Corp : Gerdes Energy Research cuts to neutral from buy

* Central Garden & Pet Co : Canaccord Genuity cuts target price to $49 from $52

* Coherus Biosciences Inc : Baird cuts target price to $8 from $9

* Elanco Animal Health Inc : Piper Sandler cuts target price to $16 from $19

* EQT Corp : Jefferies raises target price to $49 from $48

* First Citizens Bancshares : JP Morgan adds stock to its u.s. analyst focus list

* Hexcel Corp : Jefferies cuts target price to $70 from $72

* Illumina Inc : RBC cuts target price to $242 from $249

* Insmed Inc : Truist Securities raises target price to $88 from $68

* Kinetik Holdings Inc : JP Morgan raises target price to $48 from $43

* Nikola Corp : TD Cowen adjusts PT to $10 from $0.5 to reflect 1-for-30 reverse stock split

* Northern Oil and Gas Inc : Raymond James raises target price to $58 from $54

* Ovintiv Inc : Jefferies cuts target price to $68 from $69

* PTC Therapeutics Inc : Jefferies cuts target price to $43 from $46

* Rivian : Canaccord Genuity raises target price to $30 from $20

* Rivian : RBC raises target price to $14 from $11

* Rocket Pharmaceuticals Inc : Leerink Partners cuts PT to $46 from $49

* SM Energy Co : Truist Securities cuts target price to $49 from $51

* Spectrum Brands Holdings Inc : Canaccord Genuity cuts PT to $90 from $92

* Taysha Gene Therapies Inc : Piper Sandler cuts target price to $7 from $9

* Walgreens : JP Morgan cuts target price to $20 from $30

* Walgreens : TD Cowen cuts target price to $22 from $35

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))